Graham Capital Management’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-8,847
| Closed | -$249K | – | 1258 |
|
|
2023
Q4 | $249K | Sell |
8,847
-19,965
| -69% | -$561K | 0.01% | 756 |
|
|
2023
Q3 | $782K | Sell |
28,812
-82,994
| -74% | -$2.25M | 0.02% | 415 |
|
|
2023
Q2 | $3.44M | Buy |
111,806
+96,014
| +608% | +$2.95M | 0.1% | 127 |
|
|
2023
Q1 | $569K | Sell |
15,792
-55,279
| -78% | -$1.99M | 0.02% | 697 |
|
|
2022
Q4 | $2.81M | Buy |
71,071
+54,917
| +340% | +$2.17M | 0.09% | 157 |
|
|
2022
Q3 | $649K | Buy |
+16,154
| New | +$649K | 0.03% | 648 |
|
|
2022
Q2 | – | Sell |
-44,459
| Closed | -$1.73M | – | 1207 |
|
|
2022
Q1 | $1.73M | Buy |
44,459
+39,142
| +736% | +$1.52M | 0.06% | 153 |
|
|
2021
Q4 | $211K | Buy |
+5,317
| New | +$211K | 0.01% | 440 |
|